Literature DB >> 28400517

Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease.

Mingchen Chen1,2, Peter G Wolynes3,4.   

Abstract

Huntington's disease (HD) is a neurodegenerative disease caused by an abnormal expansion in the polyglutamine (polyQ) track of the Huntingtin (HTT) protein. The severity of the disease depends on the polyQ repeat length, arising only in patients with proteins having 36 repeats or more. Previous studies have shown that the aggregation of N-terminal fragments (encoded by HTT exon 1) underlies the disease pathology in mouse models and that the HTT exon 1 gene product can self-assemble into amyloid structures. Here, we provide detailed structural mechanisms for aggregation of several protein fragments encoded by HTT exon 1 by using the associative memory, water-mediated, structure and energy model (AWSEM) to construct their free energy landscapes. We find that the addition of the N-terminal 17-residue sequence ([Formula: see text]) facilitates polyQ aggregation by encouraging the formation of prefibrillar oligomers, whereas adding the C-terminal polyproline sequence ([Formula: see text]) inhibits aggregation. The combination of both terminal additions in HTT exon 1 fragment leads to a complex aggregation mechanism with a basic core that resembles that found for the aggregation of pure polyQ repeats using AWSEM. At the extrapolated physiological concentration, although the grand canonical free energy profiles are uphill for HTT exon 1 fragments having 20 or 30 glutamines, the aggregation landscape for fragments with 40 repeats has become downhill. This computational prediction agrees with the critical length found for the onset of HD and suggests potential therapies based on blocking early binding events involving the terminal additions to the polyQ repeats.

Entities:  

Keywords:  Huntington’s disease; aggregation; aggregation free energy landscape; critical length; solubility

Mesh:

Substances:

Year:  2017        PMID: 28400517      PMCID: PMC5410817          DOI: 10.1073/pnas.1702237114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Free energy landscapes for initiation and branching of protein aggregation.

Authors:  Weihua Zheng; Nicholas P Schafer; Peter G Wolynes
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-27       Impact factor: 11.205

2.  Exploring the aggregation free energy landscape of the amyloid-β protein (1-40).

Authors:  Weihua Zheng; Min-Yeh Tsai; Mingchen Chen; Peter G Wolynes
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-03       Impact factor: 11.205

3.  Energy landscapes of a mechanical prion and their implications for the molecular mechanism of long-term memory.

Authors:  Mingchen Chen; Weihua Zheng; Peter G Wolynes
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-18       Impact factor: 11.205

4.  Protein Folding and Structure Prediction from the Ground Up II: AAWSEM for α/β Proteins.

Authors:  Mingchen Chen; Xingcheng Lin; Wei Lu; José N Onuchic; Peter G Wolynes
Journal:  J Phys Chem B       Date:  2016-11-11       Impact factor: 2.991

5.  Requirement of an intact microtubule cytoskeleton for aggregation and inclusion body formation by a mutant huntingtin fragment.

Authors:  Paul J Muchowski; Ke Ning; Crislyn D'Souza-Schorey; Stanley Fields
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

Review 6.  Glutamine repeats and neurodegeneration.

Authors:  H Y Zoghbi; H T Orr
Journal:  Annu Rev Neurosci       Date:  2000       Impact factor: 12.449

7.  Slow amyloid nucleation via α-helix-rich oligomeric intermediates in short polyglutamine-containing huntingtin fragments.

Authors:  Murali Jayaraman; Ravindra Kodali; Bankanidhi Sahoo; Ashwani K Thakur; Anand Mayasundari; Rakesh Mishra; Cynthia B Peterson; Ronald Wetzel
Journal:  J Mol Biol       Date:  2011-12-09       Impact factor: 5.469

8.  Critical nucleus size for disease-related polyglutamine aggregation is repeat-length dependent.

Authors:  Karunakar Kar; Murali Jayaraman; Bankanidhi Sahoo; Ravindra Kodali; Ronald Wetzel
Journal:  Nat Struct Mol Biol       Date:  2011-02-13       Impact factor: 15.369

9.  Mutant huntingtin N-terminal fragments of specific size mediate aggregation and toxicity in neuronal cells.

Authors:  Tamara Ratovitski; Marjan Gucek; Haibing Jiang; Ekaterine Chighladze; Elaine Waldron; James D'Ambola; Zhipeng Hou; Yideng Liang; Michelle A Poirier; Ricky R Hirschhorn; Rona Graham; Michael R Hayden; Robert N Cole; Christopher A Ross
Journal:  J Biol Chem       Date:  2009-02-09       Impact factor: 5.157

10.  Identifying polyglutamine protein species in situ that best predict neurodegeneration.

Authors:  Jason Miller; Montserrat Arrasate; Elizabeth Brooks; Clare Peters Libeu; Justin Legleiter; Danny Hatters; Jessica Curtis; Kenneth Cheung; Preethi Krishnan; Siddhartha Mitra; Kartika Widjaja; Benjamin A Shaby; Gregor P Lotz; Yvonne Newhouse; Emily J Mitchell; Alex Osmand; Michelle Gray; Vanitha Thulasiramin; Frédéric Saudou; Mark Segal; X William Yang; Eliezer Masliah; Leslie M Thompson; Paul J Muchowski; Karl H Weisgraber; Steven Finkbeiner
Journal:  Nat Chem Biol       Date:  2011-10-30       Impact factor: 15.040

View more
  21 in total

Review 1.  Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities.

Authors:  Rachel J Harding; Yu-Feng Tong
Journal:  Acta Pharmacol Sin       Date:  2018-04-05       Impact factor: 6.150

2.  Surveying the Energy Landscapes of Aβ Fibril Polymorphism.

Authors:  Mingchen Chen; Nicholas P Schafer; Peter G Wolynes
Journal:  J Phys Chem B       Date:  2018-10-01       Impact factor: 2.991

Review 3.  Towards developing principles of protein folding and dynamics in the cell.

Authors:  Margaret S Cheung; Andrei G Gasic
Journal:  Phys Biol       Date:  2018-07-30       Impact factor: 2.583

4.  Exploring the interplay between fibrillization and amorphous aggregation channels on the energy landscapes of tau repeat isoforms.

Authors:  Xun Chen; Mingchen Chen; Nicholas P Schafer; Peter G Wolynes
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-06       Impact factor: 11.205

5.  Distinct oligomerization and fibrillization dynamics of amyloid core sequences of amyloid-beta and islet amyloid polypeptide.

Authors:  Yunxiang Sun; Bo Wang; Xinwei Ge; Feng Ding
Journal:  Phys Chem Chem Phys       Date:  2017-10-25       Impact factor: 3.676

Review 6.  Neurotheranostics as personalized medicines.

Authors:  Bhavesh D Kevadiya; Brendan M Ottemann; Midhun Ben Thomas; Insiya Mukadam; Saumya Nigam; JoEllyn McMillan; Santhi Gorantla; Tatiana K Bronich; Benson Edagwa; Howard E Gendelman
Journal:  Adv Drug Deliv Rev       Date:  2018-10-26       Impact factor: 15.470

7.  Thermodynamics of Huntingtin Aggregation.

Authors:  Tam T M Phan; Jeremy D Schmit
Journal:  Biophys J       Date:  2020-05-20       Impact factor: 4.033

8.  Nucleation Inhibition of Huntingtin Protein (htt) by Polyproline PPII Helices: A Potential Interaction with the N-Terminal α-Helical Region of Htt.

Authors:  James R Arndt; Maxmore Chaibva; Maryssa Beasley; Ahmad Kiani Karanji; Samaneh Ghassabi Kondalaji; Mahdiar Khakinejad; Olivia Sarver; Justin Legleiter; Stephen J Valentine
Journal:  Biochemistry       Date:  2019-12-20       Impact factor: 3.162

9.  Mutational analysis implicates the amyloid fibril as the toxic entity in Huntington's disease.

Authors:  Kenneth W Drombosky; Sascha Rode; Ravi Kodali; Tija C Jacob; Michael J Palladino; Ronald Wetzel
Journal:  Neurobiol Dis       Date:  2018-08-30       Impact factor: 5.996

10.  Abrogation of prenucleation, transient oligomerization of the Huntingtin exon 1 protein by human profilin I.

Authors:  Alberto Ceccon; Vitali Tugarinov; Rodolfo Ghirlando; G Marius Clore
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.